{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T06:52:31Z","timestamp":1790837551165,"version":"4.1.0"},"reference-count":28,"publisher":"American Society of Hematology","issue":"9","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2001,5,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>The experiences of 69 (38 marrow and 31 peripheral blood stem cell [PBSC]) donors participating in a randomized trial comparing allogeneic bone marrow with PBSC transplantation were studied. Marrow was collected by means of standard harvest techniques and general or regional anesthesia. PBSC donors were treated with 5 to 7 days of filgrastim at a dose of 16 \u03bcg\/kg\/d and underwent 1 to 3 days of apheresis to obtain 5\u2009\u00d7\u2009106 CD34+ cells per kilogram recipient weight. Donors completed questionnaires describing their health experiences before, during, and then weekly after donation until return to baseline status. Both marrow and PBSC donors reported minimal fluctuation in symptoms measuring emotional status. In contrast, both groups of donors reported deterioration in physical status starting with administration of filgrastim (PBSC donors) or after the marrow collection procedure. The symptom burden reported was similar, with pain a prominent symptom for both groups. Equivalent mean levels of maximal pain, average pain, and pain duration through the day were reported, although toxicity peaks occurred at different time points during the harvest procedures. All PBSC donors but only 79% of marrow donors reported good physical status by 14 days after the harvest procedures. These data demonstrate similar levels of physical discomfort for hematopoietic stem cell donors regardless of the collection procedure used, but a quicker resolution of symptoms for PBSC donors.<\/jats:p>","DOI":"10.1182\/blood.v97.9.2541","type":"journal-article","created":{"date-parts":[[2002,7,27]],"date-time":"2002-07-27T12:46:47Z","timestamp":1027774007000},"page":"2541-2548","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":86,"title":["Experiences of donors enrolled in a randomized study of allogeneic bone marrow or peripheral blood stem cell transplantation"],"prefix":"10.1182","volume":"97","author":[{"given":"Scott D.","family":"Rowley","sequence":"first","affiliation":[{"name":"From the Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gary","family":"Donaldson","sequence":"additional","affiliation":[{"name":"From the Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathy","family":"Lilleby","sequence":"additional","affiliation":[{"name":"From the Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William I.","family":"Bensinger","sequence":"additional","affiliation":[{"name":"From the Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frederick R.","family":"Appelbaum","sequence":"additional","affiliation":[{"name":"From the Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"key":"2020021216384720700_B1","first-page":"277","article-title":"Comparison of haematological recovery times and supportive care requirements of autologous recovery phase peripheral blood stem cell transplants, autologous bone marrow transplants and allogeneic bone marrow transplants.","volume":"9","author":"To","year":"1992","journal-title":"Bone Marrow Transplant."},{"key":"2020021216384720700_B2","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1182\/blood.V85.6.1659.bloodjournal8561659","article-title":"Allogeneic blood stem cell transplantation for refractory leukemia and lymphoma: potential advantages of blood over marrow allografts.","volume":"85","author":"Ko\u0308rbling","year":"1995","journal-title":"Blood."},{"key":"2020021216384720700_B3","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1200\/JCO.1995.13.6.1328","article-title":"Hematopoietic rescue after high-dose chemotherapy using autologous peripheral-blood progenitor cells or bone marrow: a randomized comparison.","volume":"13","author":"Beyer","year":"1995","journal-title":"J Clin Oncol."},{"key":"2020021216384720700_B4","doi-asserted-by":"crossref","first-page":"2794","DOI":"10.1182\/blood.V88.7.2794.bloodjournal8872794","article-title":"Allogeneic peripheral blood stem cell transplantation in patients with advanced hematologic malignancies: a retrospective comparison with marrow transplantation.","volume":"88","author":"Bensinger","year":"1996","journal-title":"Blood."},{"key":"2020021216384720700_B5","doi-asserted-by":"crossref","first-page":"600","DOI":"10.7326\/0003-4819-126-8-199704150-00002","article-title":"Peripheral blood stem cell and bone marrow transplantation for solid tumors and lymphomas: hematologic recovery and costs. a randomized, controlled trial.","volume":"126","author":"Hartmann","year":"1997","journal-title":"Ann Intern Med."},{"key":"2020021216384720700_B6","doi-asserted-by":"crossref","first-page":"4705","DOI":"10.1182\/blood.V90.12.4705","article-title":"Allogeneic peripheral blood stem cell transplantation may be associated with a high risk of chronic graft-versus-host disease.","volume":"90","author":"Storek","year":"1997","journal-title":"Blood."},{"key":"2020021216384720700_B7","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1056\/NEJM200101183440303","article-title":"Transplantation of bone marrow as compared with peripheral-blood stem cells from HLA-identical relatives in patients with hematologic cancers.","volume":"344","author":"Bensinger","year":"2001","journal-title":"N Engl J Med."},{"key":"2020021216384720700_B8","first-page":"903","article-title":"Allogeneic blood stem cell transplantation: considerations for donors.","volume":"90","author":"Anderlini","year":"1997","journal-title":"Blood."},{"key":"2020021216384720700_B9","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1038\/sj.bmt.1702072","article-title":"Three to six year follow-up of normal donors who received recombinant human granulocyte colony-stimulating factor.","volume":"25","author":"Cavallaro","year":"2000","journal-title":"Bone Marrow Transplant."},{"key":"2020021216384720700_B10","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1046\/j.1537-2995.1996.36796323057.x","article-title":"Clinical toxicity and laboratory effects of granulocyte-colony-stimulating factor (filgrastim) mobilization and blood stem cell apheresis from normal donors, and analysis of charges for the procedure.","volume":"36","author":"Anderlini","year":"1996","journal-title":"Transfusion."},{"key":"2020021216384720700_B11","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1046\/j.1537-2995.1996.36796323059.x","article-title":"Treatment of normal individuals with granulocyte-colony stimulating factor: donor experiences and the effects on peripheral blood CD34+ cell counts and on the collection of peripheral blood stem cells.","volume":"36","author":"Stroncek","year":"1996","journal-title":"Transfusion."},{"key":"2020021216384720700_B12","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1182\/blood.V64.3.630.630","article-title":"Marrow harvesting from normal donors.","volume":"64","author":"Buckner","year":"1984","journal-title":"Blood."},{"key":"2020021216384720700_B13","first-page":"879","article-title":"Marrow harvesting for autologous marrow transplantation.","volume":"13","author":"Jin","year":"1985","journal-title":"Exp Hematol."},{"key":"2020021216384720700_B14","first-page":"157","article-title":"Assessment and management of donor pain following marrow harvest for allogeneic bone marrow transplantation.","volume":"4","author":"Hill","year":"1989","journal-title":"Bone Marrow Transplant."},{"key":"2020021216384720700_B15","doi-asserted-by":"crossref","first-page":"1940","DOI":"10.1182\/blood.V81.7.1940.1940","article-title":"Experiences of the first 493 unrelated marrow donors in the National Marrow Donor Program.","volume":"81","author":"Stroncek","year":"1993","journal-title":"Blood."},{"key":"2020021216384720700_B16","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1182\/blood.V36.4.507.507","article-title":"Technique for human marrow grafting.","volume":"36","author":"Thomas","year":"1970","journal-title":"Blood."},{"key":"2020021216384720700_B17","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1046\/j.1537-2995.1999.39111200.x","article-title":"Collection of peripheral blood stem cells with an automated leukapheresis system.","volume":"39","author":"Rowley","year":"1999","journal-title":"Transfusion."},{"key":"2020021216384720700_B18","first-page":"129","article-title":"Pain assessment: global use of the Brief Pain Inventory.","volume":"23","author":"Cleeland","year":"1994","journal-title":"Ann Acad Med Singapore."},{"key":"2020021216384720700_B19","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/0304-3959(75)90044-5","article-title":"The McGill Pain Questionnaire: major properties and scoring methods.","volume":"1","author":"Melzack","year":"1975","journal-title":"Pain."},{"key":"2020021216384720700_B20","doi-asserted-by":"crossref","DOI":"10.1002\/9780470316696","volume-title":"Multiple Imputation for Nonresponse in Surveys.","author":"Rubin","year":"1987"},{"key":"2020021216384720700_B21","volume-title":"Statistical Analysis with Missing Data.","author":"Little","year":"1987"},{"key":"2020021216384720700_B22","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/0304-3959(94)00178-H","article-title":"When is cancer pain mild, moderate or severe? Grading pain severity by its interference with function.","volume":"61","author":"Serlin","year":"1995","journal-title":"Pain."},{"key":"2020021216384720700_B23","first-page":"503","article-title":"Fracture of the ilium: an unusual complication of bone marrow harvesting.","volume":"9","author":"Klumpp","year":"1992","journal-title":"Bone Marrow Transplant."},{"key":"2020021216384720700_B24","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1200\/JCO.1989.7.5.648","article-title":"An evaluation of outpatient bone marrow harvesting.","volume":"7","author":"Brandwein","year":"1989","journal-title":"J Clin Oncol."},{"key":"2020021216384720700_B25","first-page":"433","article-title":"Acute iritis induced by granulocyte colony-stimulating factor used for mobilization in a volunteer unrelated peripheral blood progenitor cell donor.","volume":"17","author":"Parkkali","year":"1996","journal-title":"Bone Marrow Transplant."},{"key":"2020021216384720700_B26","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1046\/j.1365-2141.1997.302677.x","article-title":"Collection of peripheral blood stem cells from normal donors 60 years of age or older.","volume":"97","author":"Anderlini","year":"1997","journal-title":"Br J Haematol."},{"key":"2020021216384720700_B27","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1089\/scd.1.1995.4.85","article-title":"Complications of peripheral blood stem cell harvesting: review of 554 PBSC leukaphereses.","volume":"4","author":"Goldberg","year":"1995","journal-title":"J Hematother."},{"key":"2020021216384720700_B28","doi-asserted-by":"crossref","first-page":"2795","DOI":"10.1182\/blood.V84.8.2795.2795","article-title":"Characterization of CD34+ peripheral blood cells from healthy adults mobilized by recombinant human granulocyte colony-stimulating factor.","volume":"84","author":"Tj\u00f8nnfjord","year":"1994","journal-title":"Blood."}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/97\/9\/2541\/1673413\/h8090102541.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/97\/9\/2541\/1673413\/h8090102541.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,2,12]],"date-time":"2020-02-12T21:38:55Z","timestamp":1581543535000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/97\/9\/2541\/130309\/Experiences-of-donors-enrolled-in-a-randomized"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,5,1]]},"references-count":28,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2001,5,1]]}},"URL":"https:\/\/doi.org\/10.1182\/blood.v97.9.2541","relation":{},"ISSN":["1528-0020","0006-4971"],"issn-type":[{"value":"1528-0020","type":"electronic"},{"value":"0006-4971","type":"print"}],"subject":[],"published":{"date-parts":[[2001,5,1]]}}}